The 464-subject PLACID trial – carried out in India – found that the use of so-called convalescent plasma was unable to prevent progression to severe disease or reduce mortality in people ...

Another trial of convalescent plasma in people with COVID-19 has missed the mark, this time in mild to moderate disease, further dashing hopes that the therapy could have an impact on the infection.

New Delhi, Apr 18 () The central drug regulator has given its go-ahead to a proposal by the Indian Council of Medical Research for the clinical trial of convalescent plasma in COVID-19 patients ...

A potential treatment for Covid using blood plasma does not reduce deaths among hospital patients, trials show. The results are a blow to researchers and the NHS, which led the drive to collect ...

"ICMR is inviting a letter of intent from institutions with the equipment and infrastructure available to participate in a clinical trial to study the safety and efficacy of convalescent plasma in ...

More than 6,500 people have signed up for a trial to see if blood plasma ... seriously ill patients with so-called convalescent blood plasma will give their struggling immune systems a helping ...

The Maui News / MATTHEW THAYER photo Convalescent plasma donations from recovered COVID-19 patients could save a life, a concept that officials say can help to treat those hospitalized with the virus.

The following is a summary of “Immunological sub-phenotypes and response to convalescent plasma in COVID-19 induced ARDS: a ...